<VariationArchive VariationID="818014" VariationName="NM_015046.7(SETX):c.6897dup (p.Phe2300fs)" VariationType="Duplication" Accession="VCV000818014" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-03-05" DateCreated="2020-03-16" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="805609" VariationID="818014">
      <GeneList>
        <Gene Symbol="SETX" FullName="senataxin" GeneID="23064" HGNC_ID="HGNC:445" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="132261356" stop="132356744" display_start="132261356" display_stop="132356744" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="135136826" stop="135230371" display_start="135136826" display_stop="135230371" Strand="-" />
          </Location>
          <OMIM>608465</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015046.7(SETX):c.6897dup (p.Phe2300fs)</Name>
      <CanonicalSPDI>NC_000009.12:132277097:C:CC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q34.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="132277097" stop="132277098" display_start="132277097" display_stop="132277098" variantLength="1" positionVCF="132277097" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="135152484" stop="135152485" display_start="135152484" display_stop="135152485" variantLength="1" positionVCF="135152484" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
      </Location>
      <ProteinChange>F2300fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.135152485dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.135152485dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.132277098dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.132277098dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007946.1" sequenceAccession="NG_007946" sequenceVersion="1" change="g.82888dup">
            <Expression>NG_007946.1:g.82888dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351527.2" sequenceAccession="NM_001351527" sequenceVersion="2" change="c.6897dup">
            <Expression>NM_001351527.2:c.6897dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338456.1" sequenceAccession="NP_001338456" sequenceVersion="1" change="p.Phe2300fs">
            <Expression>NP_001338456.1:p.Phe2300fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351528.2" sequenceAccession="NM_001351528" sequenceVersion="2" change="c.6897dup">
            <Expression>NM_001351528.2:c.6897dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338457.1" sequenceAccession="NP_001338457" sequenceVersion="1" change="p.Phe2300fs">
            <Expression>NP_001338457.1:p.Phe2300fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015046.7" sequenceAccession="NM_015046" sequenceVersion="7" change="c.6897dup" MANESelect="true">
            <Expression>NM_015046.7:c.6897dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055861.3" sequenceAccession="NP_055861" sequenceVersion="3" change="p.Phe2300fs">
            <Expression>NP_055861.3:p.Phe2300fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_268" sequenceAccession="LRG_268">
            <Expression>LRG_268:g.82888dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_268t1" sequenceAccession="LRG_268t1">
            <Expression>LRG_268t1:c.6897dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1331217337" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015046.7(SETX):c.6897dup (p.Phe2300fs) AND not provided" Accession="RCV001009256" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015046.7(SETX):c.6897dup (p.Phe2300fs) AND Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2" Accession="RCV003233924" Version="1">
        <ClassifiedConditionList TraitSetID="583">
          <ClassifiedCondition DB="MedGen" ID="C1853761">Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015046.7(SETX):c.6897dup (p.Phe2300fs) AND multiple conditions" Accession="RCV002549297" Version="2">
        <ClassifiedConditionList TraitSetID="11687">
          <ClassifiedCondition DB="MedGen" ID="C1865409">Amyotrophic lateral sclerosis type 4</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1853761">Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-06" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2020-03-16" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14770181</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="11687" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="241" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE</ElementValue>
                <XRef Type="MIM" ID="602433" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608465.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608465.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608465.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES</ElementValue>
                <XRef Type="MIM" ID="602433" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Amyotrophic lateral sclerosis type 4</ElementValue>
                <XRef ID="MONDO:0011223" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALS4</ElementValue>
                <XRef Type="MIM" ID="602433" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10502" />
                <XRef ID="10502" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301623</ID>
                <ID Source="BookShelf">NBK1450</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AmyotrophicLateralSclerosis.pdf</URL>
                <CitationText>Orphanet, Amyotrophic lateral sclerosis, 2007</CitationText>
              </Citation>
              <XRef ID="357043" DB="Orphanet" />
              <XRef ID="C1865409" DB="MedGen" />
              <XRef ID="MONDO:0011223" DB="MONDO" />
              <XRef Type="MIM" ID="602433" DB="OMIM" />
            </Trait>
            <Trait ID="4185" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2</ElementValue>
                <XRef ID="MONDO:0018996" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia with Oculomotor Apraxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-ocular apraxia-2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-oculomotor apraxia 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AOA2</ElementValue>
                <XRef Type="MIM" ID="606002" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SCAN2</ElementValue>
                <XRef Type="MIM" ID="606002" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Ataxia with oculomotor apraxia type 2 (AOA2) is characterized by onset of ataxia between age three and 30 years after initial normal development, axonal sensorimotor neuropathy, oculomotor apraxia, cerebellar atrophy, and elevated serum concentration of alpha-fetoprotein (AFP).</Attribute>
                <XRef ID="NBK1154" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12860" />
                <XRef ID="12860" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301333</ID>
                <ID Source="BookShelf">NBK1154</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <XRef ID="64753" DB="Orphanet" />
              <XRef ID="C1853761" DB="MedGen" />
              <XRef ID="MONDO:0018996" DB="MONDO" />
              <XRef Type="MIM" ID="606002" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="583" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4185" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2</ElementValue>
                <XRef ID="MONDO:0018996" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia with Oculomotor Apraxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-ocular apraxia-2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-oculomotor apraxia 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AOA2</ElementValue>
                <XRef Type="MIM" ID="606002" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SCAN2</ElementValue>
                <XRef Type="MIM" ID="606002" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Ataxia with oculomotor apraxia type 2 (AOA2) is characterized by onset of ataxia between age three and 30 years after initial normal development, axonal sensorimotor neuropathy, oculomotor apraxia, cerebellar atrophy, and elevated serum concentration of alpha-fetoprotein (AFP).</Attribute>
                <XRef ID="NBK1154" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12860" />
                <XRef ID="12860" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301333</ID>
                <ID Source="BookShelf">NBK1154</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <XRef ID="64753" DB="Orphanet" />
              <XRef ID="C1853761" DB="MedGen" />
              <XRef ID="MONDO:0018996" DB="MONDO" />
              <XRef Type="MIM" ID="606002" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2307070" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:2779242|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001169077" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.6897dupG variant in the SETX gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.6897dupG variant causes a frameshift starting with codon Phenylalanine 2300, changes this amino acid to a Valine residue, and creates a premature Stop codon at position 2 of the new reading frame, denoted p.Phe2300ValfsX2. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.6897dupG variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.6897dupG as a likely pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SETX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015046.5:c.6897dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7349940" SubmissionDate="2023-05-28" DateLastUpdated="2023-06-17" DateCreated="2023-06-17">
        <ClinVarSubmissionID localKey="NM_015046.7:c.6897dup|OMIM:606002" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003932054" DateUpdated="2023-06-17" DateCreated="2023-06-17" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SETX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015046.7:c.6897dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606002" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13477554</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6186402" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4171672|MedGen:C1865409;C1853761" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003496273" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14770181</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe2300Valfs*2) in the SETX gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SETX are known to be pathogenic (PMID: 14770181). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SETX-related conditions. ClinVar contains an entry for this variant (Variation ID: 818014). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SETX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.135152484_135152485insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1865409" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1853761" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7349940" TraitType="Disease" MappingType="XRef" MappingValue="606002" MappingRef="OMIM">
        <MedGen CUI="C1853761" Name="Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307070" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6186402" TraitType="Disease" MappingType="XRef" MappingValue="C1853761" MappingRef="MedGen">
        <MedGen CUI="C1853761" Name="Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6186402" TraitType="Disease" MappingType="XRef" MappingValue="C1865409" MappingRef="MedGen">
        <MedGen CUI="C1865409" Name="Amyotrophic lateral sclerosis type 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

